LSU Health Shreveport is pleased to announce three new department chairs. Matthew Woolard, PhD, has been named Chair of the Department of Microbiology and Immunology at LSU Health Shreveport. Dr.

An oncology nurse treated her patients throughout the worst days of the pandemic—but a golf ball–size lump was a clue to her ...

The Pediatric Emergency Medicine and Pediatric Hematology/Oncology divisions at MUSC have joined forces to create and test an ...

Causes of chest pain, some benign and some serious, include heart attack, angina ... A pulmonary embolism occurs when a blood clot blocks a lung artery, damaging the lungs and causing low oxygen ...

Heart disease refers to any problem affecting the heart, such as coronary artery disease, arrhythmia, and heart failure. Symptoms and treatments depend on the type of heart disease someone has ...

Under the predominant clinical medical model, we have become accustomed to treating symptoms rather than managing, preventing ...

[16] Thus, there was considerable surprise and maybe more so, disappointment, when the National Heart, Lung, and Blood Institute (NHLBI) announced that doxazosin was being withdrawn from the trial ...

There’s no way around it: If you smoke, you’re more likely to develop many serious conditions, from cancer and lung disease to heart disease and diabetes. That’s why doctors say you’ll ...

If you have depression, you probably know all too well how this condition hurts your heart emotionally, but did you know that depression can take a physical toll on your ticker, too — and vice ...

The landscape of complex lung disease diagnosis and treatment has undergone a significant transformation in recent years, driven by advancements in AI and machine learning technologies.

This increases the likelihood of high blood pressure, heart attack, and stroke if not controlled. Scientists have found that when people have more than one risk factor, like high blood cholesterol ...

Merck & Co's earlier efforts to find new therapies for Alzheimer's disease resulted in failure, but the company is returning to the field via an R&D alliance with UK biotech Cerevance that will ...